查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1312320

臨床前影像市場：副產品（模式、試劑）、用途（藥物研發發現、研發）、最終用戶 - COVID-19 的累積影響、俄羅斯-烏克蘭衝突、高通貨膨脹 - 2023-2030 年全球預測

Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球臨床前影像市場預計到 2023 年將達到 25.3015 億美元，年複合成長率為 6.51%，預計到 2030 年將出現驚人的成長，達到 39.397 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球臨床前影像市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 臨床前影像的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球臨床前影像市場的阻礙因素和影響為何？

3. 在預測期內，全球臨床前影像市場需要投資哪些產品/細分市場/應用/領域？

4.全球臨床前影像市場的競爭策略為何？

5. 全球臨床前影像市場的技術趨勢和法律規範是什麼？

6.全球臨床前影像市場主要廠商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球臨床前影像市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 擴大影像診斷適應症
      • 對非侵入性診斷和治療設備的需求不斷成長
      • 臨床研究組織（CRO）和製藥公司的數量正在增加
    • 抑制因素
      • 缺乏覆蓋範圍
    • 機會
      • 分子影像技術進步
      • 增加私人和公共機構對臨床前研究的資助
    • 任務
      • 嚴格法規結構下的臨床前研究
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 臨床前影像市場：副產品

  • 情態
    • 磁粒子成像
    • 磁振造影
    • 顯微電腦斷層掃描
    • 光學成像
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 試劑
    • 生物發光成像試劑
    • 螢光成像試劑
    • MRI顯影劑
    • PET放射性追蹤劑
    • 超音波顯影劑
    • X光CT顯影劑

第7章 臨床前影像市場：依用途

  • 藥物研發
  • 研究與開發

第8章 臨床前影像市場：依最終使用者分類

  • 生技公司
  • 製藥公司
  • 調查機構

第9章 美洲臨床前影像市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太臨床前影像市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲臨床前影像市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-030EE48515D4

The Global Preclinical Imaging Market is forecasted to grow significantly, with a projected USD 2,530.15 million in 2023 at a CAGR of 6.51% and expected to reach a staggering USD 3,939.70 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Preclinical Imaging Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Preclinical Imaging Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Modalities and Reagents. The Modalities is further studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-Computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-Photon Emission Computed Tomography. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents. The Modalities is projected to witness significant market share during forecast period.

Based on Application, market is studied across Drug Discovery and Research & Development. The Drug Discovery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biotech Companies, Pharmaceutical Companies, and Research Institutes. The Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Preclinical Imaging Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Preclinical Imaging Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Preclinical Imaging Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Preclinical Imaging Market?

4. What is the competitive strategic window for opportunities in the Global Preclinical Imaging Market?

5. What are the technology trends and regulatory frameworks in the Global Preclinical Imaging Market?

6. What is the market share of the leading vendors in the Global Preclinical Imaging Market?

7. What modes and strategic moves are considered suitable for entering the Global Preclinical Imaging Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Preclinical Imaging Market, by Product, 2022 vs 2030
  • 4.3. Preclinical Imaging Market, by Application, 2022 vs 2030
  • 4.4. Preclinical Imaging Market, by End-User, 2022 vs 2030
  • 4.5. Preclinical Imaging Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adaptation of diagnostic imaging
      • 5.1.1.2. Rising demand for non-invasive diagnostics and therapeutic devices
      • 5.1.1.3. Growing number of clinical research organizations (CROs) and pharmaceutical companies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement coverage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in molecular imaging
      • 5.1.3.2. Increase in preclinical research funding, by both private and public organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework preclinical research
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Preclinical Imaging Market, by Product

  • 6.1. Introduction
  • 6.2. Modalities
    • 6.2.1. Magnetic Particle Imaging
    • 6.2.2. Magnetic Resonance Imaging
    • 6.2.3. Micro-Computed Tomography
    • 6.2.4. Optical Imaging
    • 6.2.5. Positron Emission Tomography
    • 6.2.6. Single-Photon Emission Computed Tomography
  • 6.3. Reagents
    • 6.3.1. Bioluminescent Imaging Reagents
    • 6.3.2. Fluorescent Imaging Reagents
    • 6.3.3. MRI Contrasting Reagents
    • 6.3.4. PET Radioactive Tracers
    • 6.3.5. Ultrasound Contrasting Reagents
    • 6.3.6. X-ray CT Contrasting Reagents

7. Preclinical Imaging Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Research & Development

8. Preclinical Imaging Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotech Companies
  • 8.3. Pharmaceutical Companies
  • 8.4. Research Institutes

9. Americas Preclinical Imaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Preclinical Imaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Preclinical Imaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL IMAGING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. PRECLINICAL IMAGING MARKET DYNAMICS
  • FIGURE 9. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 14. PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. PRECLINICAL IMAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 238. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 239. PRECLINICAL IMAGING MARKET LICENSE & PRICING